SkyLimit2022
16 minutes ago
ex,
The novel DCVax-L cell-based platform and EDEN are both patent-fortified technologies owned by Northwest Biotherapeutics, but nobody is suggesting that their dominant position reflects a zero-sum game. NWBO will protect its intellectual property and proprietary processes, but th